Core Scientific, Inc. Form 8-K Summary
Business Context and Reporting Period
Core Scientific, Inc. filed a Form 8-K dated January 9, 2023, under Item 7.01 to furnish production and operations updates for November and December 2022. The filing references a related press release as Exhibit 99.1, but the press release text is not included in the provided filing content.
The company’s common stock and warrants began trading exclusively on the OTC Pink Marketplace on January 3, 2023, under the symbols CORZQ and CRZWQ, respectively.
Financial and Operating Metrics
- The provided filing text does not include revenue, profit, cash flow, margins, debt, liquidity, production, mining, or other operating metrics.
- The filing text does not provide clear values for November or December 2022 production or operations.
Material Changes Versus the Prior Comparable Period
- The filing announces production and operations updates for November and December 2022, but the underlying data and comparison to prior periods are not included in the provided text.
- The company’s securities moved to exclusive OTC Pink Marketplace trading effective January 3, 2023.
Guidance, Outlook, Risks, and Unusual Items
- No guidance or financial outlook is provided in the filing text.
- No new risks, contingencies, or unusual financial items are described in the filing text.
- Item 7.01 information, including Exhibit 99.1, is furnished and is not deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings.
Investor Verification Items
- Obtain and review Exhibit 99.1 for the November and December 2022 production and operations data.
- Verify the implications of the company’s January 3, 2023 transition to OTC Pink Marketplace trading.
- Review subsequent filings for financial condition, debt, liquidity, restructuring, and operating updates, none of which are quantified in this filing.